{"transactions":[{"id":687134,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T21:44:43.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":13192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vest in accordance with the applicable grant agreement."}],"balance_after":29321,"source":{"system":"sec-edgar","filing":"0001239594-26-000008","document":"wk-form4_1786743879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000123959426000008/wk-form4_1786743879.xml","form_type":"4"}},{"id":877748,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T23:07:35.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":5509,"price":20.06,"value":110510.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026."}],"balance_after":24138,"source":{"system":"sec-edgar","filing":"0001239594-26-000005","document":"wk-form4_1772233651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000123959426000005/wk-form4_1772233651.xml","form_type":"4"}},{"id":940206,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-01-13T23:37:09.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable. These securities were previously reported on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":18.6,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001239594-26-000003","document":"wk-form4_1768347427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000123959426000003/wk-form4_1768347427.xml","form_type":"4"}},{"id":940205,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T23:37:09.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":18.6,"value":46500.0,"ownership":{"direct":true},"balance_after":18629,"source":{"system":"sec-edgar","filing":"0001239594-26-000003","document":"wk-form4_1768347427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000123959426000003/wk-form4_1768347427.xml","form_type":"4"}},{"id":1104141,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-06-23T22:31:04.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":40983607,"ownership":{"direct":false,"nature":"By CLS-PF-SPE, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10245906},"source":{"system":"sec-edgar","filing":"0001104659-25-061804","document":"tm2518641-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061804/tm2518641-2_4seq1.xml","form_type":"4"}},{"id":1104140,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-23T22:31:04.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable. These securities were previously reported on the Reporting Person's Form 3."}],"balance_after":2500,"derivative":{"exercise_price":18.6,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-25-061804","document":"tm2518641-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061804/tm2518641-2_4seq1.xml","form_type":"4"}},{"id":1104139,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T22:31:04.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":10245906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CLS-PF-SPE, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":10270906,"source":{"system":"sec-edgar","filing":"0001104659-25-061804","document":"tm2518641-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061804/tm2518641-2_4seq1.xml","form_type":"4"}},{"id":1104138,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23442,"kind":"person","name":"CASTLEMAN PETER M","position":1,"cik":"0001239594","reported_name":"CASTLEMAN PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T22:31:04.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":16129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. These restricted stock units were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025."}],"balance_after":16129,"source":{"system":"sec-edgar","filing":"0001104659-25-061804","document":"tm2518641-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061804/tm2518641-2_4seq1.xml","form_type":"4"}}]}